Transdermal delivery system

Details Transdermal delivery system Transdermal delivery system

A - Human Necessities

61

K

167/159

A61K 47/00 (2006.01) A61K 9/70 (2006.01) A61K 31/21 (2006.01) A61K 31/565 (2006.01) A61K 47/10 (2006.01) A61K 47/12 (2006.01)

Patent

CA 1280974

ABSTRACT OF THE DISCLOSURE Pharmaceutical preparations comprised of a pharmaceutically active ingredient and a carrier which comprises a percutaneous penetration enhancer comprised of 2-ethyl-1, 3-hexanediol and/or oleic acid is disclosed. The 2-ethyl-1, 3-hexanediol may be present in an amount in the range of about 50% to 100% based on the weight of the carrier. The oleic acid may be used in combination with 2-ethyl-1, 3-hexanediol in an amount of about 1 to 40% based on the weight of the carrier to provide a synergistic effect with respect to percutaneous penetration enhancement. The compound 2-ethyl-1, 3-hexanediol as used alone and/or in combination with the oleic acid has been found to significantly enhance the delivery of a drug, to a patient, from a transdermal delivery system.

524665

Affiliated with

Also associated with

Rating

Transdermal delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal delivery system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1183209